Shanghai Pharmaceuticals Holding Co Ltd (601607)

Currency in CNY
17.40
-0.03(-0.17%)
Closed·
601607 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.3817.50
52 wk Range
17.2320.77
Key Statistics
Bid/Ask
17.40 / 17.41
Prev. Close
17.43
Open
17.43
Day's Range
17.38-17.5
52 wk Range
17.23-20.77
Volume
15.04M
Average Volume (3m)
14.84M
1-Year Change
-13.6476%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
601607 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.52
Upside
+17.92%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Shanghai Pharmaceuticals Holding Co Ltd Company Profile

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. It also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

Employees
49402
Market
China

Compare 601607 to Peers and Sector

Metrics to compare
601607
Peers
Sector
Relationship
P/E Ratio
10.4x20.3x−0.6x
PEG Ratio
0.25−0.750.00
Price/Book
0.8x1.4x2.6x
Price / LTM Sales
0.2x0.5x3.4x
Upside (Analyst Target)
24.8%27.6%42.5%
Fair Value Upside
Unlock19.3%5.0%Unlock

Analyst Ratings

8 Buy
2 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 20.52
(+17.92% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
HSBC
Hold18.70+7.47%19.30MaintainNov 11, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.53%
Dividend Yield
2.35%
Industry Median 1.45%
Annualized payout
0.41
Paid annually
5-Years Growth
-1.40%
Growth Streak

Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
0.19 / 0.32
Revenue / Forecast
73.48B / 73.93B
EPS Revisions
Last 90 days

601607 Income Statement

People Also Watch

28.06
600089
-0.85%
37.71
600489
+10.01%
33.62
600487
+5.52%
10.05
600000
-1.47%
93.47
600118
-2.94%

FAQ

What Is the Shanghai Pharm (601607) Stock Price Today?

The Shanghai Pharm stock price today is 17.40

What Stock Exchange Does Shanghai Pharm Trade On?

Shanghai Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Shanghai Pharm?

The stock symbol for Shanghai Pharm is "601607."

Does Shanghai Pharm Pay Dividends? What’s The Current Dividend Yield?

The Shanghai Pharm dividend yield is 2.35%.

What Is the Shanghai Pharm Market Cap?

As of today, Shanghai Pharm market cap is 64.60B.

What Is Shanghai Pharm's Earnings Per Share (TTM)?

The Shanghai Pharm EPS (TTM) is 1.53.

When Is the Next Shanghai Pharm Earnings Date?

Shanghai Pharm will release its next earnings report on Mar 31, 2026.

From a Technical Analysis Perspective, Is 601607 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Shanghai Pharm Stock Split?

Shanghai Pharm has split 6 times.

How Many Employees Does Shanghai Pharm Have?

Shanghai Pharm has 49402 employees.

What is the current trading status of Shanghai Pharm (601607)?

As of Jan 28, 2026, Shanghai Pharm (601607) is trading at a price of 17.40, with a previous close of 17.43. The stock has fluctuated within a day range of 17.38 to 17.50, while its 52-week range spans from 17.23 to 20.77.

What Is Shanghai Pharm (601607) Price Target According to Analysts?

The average 12-month price target for Shanghai Pharm is CNY20.52, with a high estimate of CNY24.44 and a low estimate of CNY12.2. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +17.92% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.